Why Is Sangamo Therapeutics (SGMO) Stock Up 52% Today?
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Sangamo Therapeutics stock is heading higher on Tuesday as SGMO investors react to a new $50 million license agreement.
The post Why Is Sangamo Therapeutics (SGMO) Stock Up 52% Today? appeared first on InvestorPlace.
More From InvestorPlace